Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2021. Start Trial.
Date Value
September 30, 2026 52.70M
June 30, 2026 51.51M
March 31, 2026 57.34M
December 31, 2025 69.65M
September 30, 2025 74.71M
June 30, 2025 78.97M
March 31, 2025 85.61M
December 31, 2024 74.97M
September 30, 2024 72.34M
June 30, 2024 75.19M
March 31, 2024 67.09M
Date Value
December 31, 2023 66.94M
September 30, 2023 64.02M
June 30, 2023 59.65M
March 31, 2023 57.15M
December 31, 2022 53.58M
September 30, 2022 45.06M
June 30, 2022 34.90M
March 31, 2022 26.29M
December 31, 2021 16.08M
September 30, 2021 11.70M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Replimune Group, Inc. 188.02M
Korsana Biosciences, Inc. 43.39M
IRulya Therapeutics, Inc. 30.76M
Q32 Bio, Inc. 15.94M
Bridgebio Oncology Therapeutics, Inc. 156.69M